Literature DB >> 1035153

Prognostic significance of ploidy level in human tumours. II extra-uterine cancers and summary of data on 1171 tumours.

N B Atkin.   

Abstract

The 5-year survival rate of 78 patients with carcinoma of the ovary showed that the prognosis was significantly better when the tumour modal DNA value was in the diploid region than when it was near-triploid or above. Similar data on 140 patients with carcinoma of the breast and 52 with carcinoma of the bladder also suggested a better prognosis for the near-diploid tumours. Among 105 carcinomas of the large bowel, however, there were more survivors in the high-ploidy than in the near-diploid group, although the difference was not statistically significant. The varying relationship between ploidy and prognosis, depending on the site or histological type of the tumour, is briefly discussed on the basis of the 1171 cases included in the present and a previous paper.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1035153

Source DB:  PubMed          Journal:  Cytobios        ISSN: 0011-4529


  5 in total

1.  DNA index--parameter for the prediction of prognosis and primary radioresistance?

Authors:  W Wagner
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The heterogeneity of solid human xenotransplant tumours.

Authors:  W Wagner
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma?

Authors:  B F Banner; J E Tomas-De La Vega; D L Roseman; J S Coon
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

4.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

5.  DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Authors:  M Tytor; G Franzén; J Olofsson; U Brunk; B Nordenskjöld
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.